| # | Drug | Count |
|---|---|---|
| 0 | CIPROFLOXACIN HYDROCHLORIDE | 22 |
| 1 | CIPROFLOXACIN | 21 |
| 2 | CIPROFLOXACIN TABLETS | 20 |
| 3 | CIPROFOLXACIN | 20 |
| 4 | VANCOMYCIN HYDROCHLORIDE | 13 |
| 5 | CEFIXIME | 11 |
| 6 | METRONIDAZOLE | 11 |
| 7 | MYCOPHENOLATE MOFETIL | 11 |
| 8 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 11 |
| 9 | PREDNISOLONE | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PAROMOMYCIN SULFATE | 1 | 0.0094 |
| 1 | CEFIXIME | 11 | 0.0036 |
| 2 | TRIHEPTANOIN | 1 | 0.0018 |
| 3 | VANCOMYCIN HYDROCHLORIDE | 13 | 0.0016 |
| 4 | INFLIXIMAB-DYYB | 5 | 0.0015 |
| 5 | AMPICILLIN AND SULBACTAM | 1 | 0.0011 |
| 6 | SOLIFENACIN SUCCIATE | 2 | 0.0010 |
| 7 | CEFPODOXIME PROXETIL | 1 | 0.0010 |
| 8 | MITOXANTRONE HYDROCHLORIDE | 5 | 0.0008 |
| 9 | CEFTAZIDIME | 6 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 27 |
| 1 | Fluoroquinolone Antibacterial [EPC] | 27 |
| 2 | Proton Pump Inhibitor [EPC] | 15 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 14 |
| 4 | Glycopeptide Antibacterial [EPC] | 13 |
| 5 | Kinase Inhibitor [EPC] | 12 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 12 |
| 7 | Nitroimidazole Antimicrobial [EPC] | 11 |
| 8 | Aminosalicylate [EPC] | 9 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Medium-chain Triglyceride [EPC] | 1 | 0.0018 |
| 1 | Chemokine Receptor Type 4 Interaction [EPC] | 1 | 0.0007 |
| 2 | Monobactam Antibacterial [EPC] | 1 | 0.0004 |
| 3 | Phosphate Binder [EPC] | 1 | 0.0003 |
| 4 | Quinolone Antimicrobial [EPC] | 3 | 0.0003 |
| 5 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 6 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 7 | Echinocandin Antifungal [EPC] | 2 | 0.0002 |
| 8 | Fluoroquinolone Antibacterial [EPC] | 27 | 0.0002 |
| 9 | Glycopeptide Antibacterial [EPC] | 13 | 0.0002 |